Congrats to patient advocate/CEO John Crowley, who will be taking over as the CEO of the Biotechnology Innovation Organization. No one knows the stakes of drug development better than John,
Programming Note: Cost Curve is off tomorrow, back Monday. If you’re looking to get a value fix, though, the Drug Channels webinar on 340B is tomorrow. The topic couldn’t be
Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv